Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4033009019 | Satralizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4033010012 | Satralizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Satralizumab (substance) | est un(e) (attribut) | Immunosuppressant (substance) | true | Inferred relationship | Some | ||
Satralizumab (substance) | est un(e) (attribut) | Monoclonal antibody (substance) | true | Inferred relationship | Some | ||
Satralizumab (substance) | est un(e) (attribut) | Interleukin 6 receptor antagonist | true | Inferred relationship | Some | ||
Satralizumab (substance) | Has disposition (attribute) | Interleukin 6 receptor antagonist (disposition) | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Satralizumab-containing product | a pour principe actif (attribut) | True | Satralizumab (substance) | Inferred relationship | Some | 1 |
Satralizumab only product | a pour principe actif (attribut) | True | Satralizumab (substance) | Inferred relationship | Some | 1 |
Satralizumab-containing product in parenteral dose form | a pour principe actif (attribut) | True | Satralizumab (substance) | Inferred relationship | Some | 1 |
Product containing only satralizumab in parenteral dose form (medicinal product form) | a pour principe actif (attribut) | True | Satralizumab (substance) | Inferred relationship | Some | 1 |
This concept is not in any reference sets